Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2001 Oct;71(4):433–435. doi: 10.1136/jnnp.71.4.433

Bickerstaff's encephalitis and the Miller Fisher syndrome

J Winer 1
PMCID: PMC1763522  PMID: 11561023

Full Text

The Full Text of this article is available as a PDF (101.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Din A. N., Anderson M., Bickerstaff E. R., Harvey I. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain. 1982 Sep;105(Pt 3):481–495. doi: 10.1093/brain/105.3.481. [DOI] [PubMed] [Google Scholar]
  2. BICKERSTAFF E. R., CLOAKE P. C. P. Mesencephalitis and rhombencephalitis. Br Med J. 1951 Jul 14;2(4723):77–81. doi: 10.1136/bmj.2.4723.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barontini F., Sitá D. The nosological position of Fisher's syndrome (ophthalmoplegia, ataxia and areflexia). J Neurol. 1983;229(1):33–44. doi: 10.1007/BF00313494. [DOI] [PubMed] [Google Scholar]
  4. Buchwald B., Dudel J., Toyka K. V. Neuromuscular blockade by immunoglobulin G from patients with Miller Fisher syndrome. Ann N Y Acad Sci. 1998 May 13;841:659–669. doi: 10.1111/j.1749-6632.1998.tb10999.x. [DOI] [PubMed] [Google Scholar]
  5. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993 Oct;43(10):1911–1917. doi: 10.1212/wnl.43.10.1911. [DOI] [PubMed] [Google Scholar]
  6. Chiba A., Kusunoki S., Shimizu T., Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992 Jun;31(6):677–679. doi: 10.1002/ana.410310619. [DOI] [PubMed] [Google Scholar]
  7. Derakhshan I., Lotfi J., Kaufman B. Ophthalmoplegia, ataxia and hyporeflexia (Fisher's syndrome). With a midbrain lesion demonstrated by CT scanning. Eur Neurol. 1979;18(6):361–366. doi: 10.1159/000115105. [DOI] [PubMed] [Google Scholar]
  8. Enders U., Karch H., Toyka K. V., Michels M., Zielasek J., Pette M., Heesemann J., Hartung H. P. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol. 1993 Aug;34(2):136–144. doi: 10.1002/ana.410340208. [DOI] [PubMed] [Google Scholar]
  9. FISHER M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956 Jul 12;255(2):57–65. doi: 10.1056/NEJM195607122550201. [DOI] [PubMed] [Google Scholar]
  10. Jacobs B. C., Hazenberg M. P., van Doorn P. A., Endtz H. P., van der Meché F. G. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J Infect Dis. 1997 Mar;175(3):729–733. doi: 10.1093/infdis/175.3.729. [DOI] [PubMed] [Google Scholar]
  11. Landau W. M., Glenn C., Dust G. MRI in Miller Fisher variant of Guillain-Barré syndrome. Neurology. 1987 Aug;37(8):1431–1431. doi: 10.1212/wnl.37.8.1431. [DOI] [PubMed] [Google Scholar]
  12. Meienberg O., Ryffel E. Supranuclear eye movement disorders in Fisher's syndrome of ophthalmoplegia, ataxia, and areflexia. Report of a case and literature review. Arch Neurol. 1983 Jul;40(7):402–405. doi: 10.1001/archneur.1983.04050070032005. [DOI] [PubMed] [Google Scholar]
  13. Ozawa T., Onodera O., Inuzuka T., Soma Y., Tsuji S. Efficacy of early plasmapheresis in Bickerstaff's encephalitis. Intern Med. 1998 Nov;37(11):986–989. doi: 10.2169/internalmedicine.37.986. [DOI] [PubMed] [Google Scholar]
  14. Plomp J. J., Molenaar P. C., O'Hanlon G. M., Jacobs B. C., Veitch J., Daha M. R., van Doorn P. A., van der Meché F. G., Vincent A., Morgan B. P. Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol. 1999 Feb;45(2):189–199. doi: 10.1002/1531-8249(199902)45:2<189::aid-ana9>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  15. Roberts M., Willison H., Vincent A., Newsom-Davis J. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet. 1994 Feb 19;343(8895):454–455. doi: 10.1016/s0140-6736(94)92694-8. [DOI] [PubMed] [Google Scholar]
  16. Ropper A. H., Shahani B. Proposed mechanism of ataxia in Fisher's syndrome. Arch Neurol. 1983 Sep;40(9):537–538. doi: 10.1001/archneur.1983.04050080037004. [DOI] [PubMed] [Google Scholar]
  17. Ropper A. H. The CNS in Guillain-Barré syndrome. Arch Neurol. 1983 Jul;40(7):397–398. doi: 10.1001/archneur.1983.04050070027003. [DOI] [PubMed] [Google Scholar]
  18. Willison H. J., Veitch J., Paterson G., Kennedy P. G. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):204–206. doi: 10.1136/jnnp.56.2.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Yuki N. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome. J Infect Dis. 1997 Dec;176 (Suppl 2):S150–S153. doi: 10.1086/513800. [DOI] [PubMed] [Google Scholar]
  20. Yuki N., Wakabayashi K., Yamada M., Seki K. Overlap of Guillain-Barre syndrome and Bickerstaff's brainstem encephalitis. J Neurol Sci. 1997 Jan;145(1):119–121. doi: 10.1016/s0022-510x(96)00251-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES